Rare diseases
Investigational molecules
Locations
10 Rue Du General Leclerc, 93370 Montfermeil, France
Groupe Hospitalier Intercommunal Le Raincy Montfermeil in Montfermeil, France specialises in clinical trials of conditions such as Asthma, Colitis ulcerative, Osteoarthritis, Chondrocalcinosis, and other specialisations. This site conducts important research.
More sites in MontfermeilFrance
Clinical trials currently enrolling participants at this site.
A Study of Brenipatide Compared to Placebo for Adults with Uncontrolled Moderate to Severe Asthma
FranceStudy of icotrokinra for adults with moderately to severely active Crohn's disease
FranceTesting icotrokinra compared to placebo for adults and adolescents with moderately to severely active ulcerative colitis
FranceStudy of SAR444336 in Adults with Microscopic Colitis Who Achieved Clinical Remission with Budesonide Treatment
FranceStudy on Stopping Omalizumab in Patients with Well-Controlled Severe Allergic Asthma After 3 Years of Treatment
FranceStudy of drug combination therapy in asymptomatic patients with frequent premature ventricular contractions and normal heart function to prevent left ventricular dysfunction
FranceStudy on the Effect of Genicular Arteries Embolization with Ioversol and Ethyl Esters of Iodised Fatty Acids in Patients with Symptomatic Knee Osteoarthritis
FranceStudy on Abatacept for Rheumatoid Arthritis in Patients Responding to Initial TNF Inhibitor Treatment
FranceStudy of hydroxychloroquine with low-dose corticosteroids compared to medium-dose corticosteroids in patients with pulmonary sarcoidosis
FranceMorning Versus Afternoon Pembrolizumab, Carboplatin, and Pemetrexed in Adults With Stage IV Non-Squamous Non-Small Cell Lung Cancer
FranceA study to evaluate the effect of topical clobetasol propionate versus a placebo for the treatment of inflammatory hand osteoarthritis in adults.
FranceStudy of tocilizumab compared to placebo in patients with chronic chondrocalcinosis who did not respond to standard treatments
FranceGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
